Benign Prostatic Hyperplasia Treatment Market is Projected to Reach USD 18.5 Billion by 2033
The global benign prostatic hyperplasia treatment market size was valued at USD 12.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 18.5 Billion by 2033, exhibiting a CAGR of 4.4% during 2025-2033.